Frankfurt - Delayed Quote EUR
Adaptimmune Therapeutics plc (473A.F)
0.2180
+0.0290
+(15.34%)
At close: April 25 at 3:49:30 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BERTRAND WILLIAM C JR Chief Operating Officer | Sale | Jan 17, 2025 | 7,510 |
| LUNGER JOHN Officer | Sale | Jan 17, 2025 | 7,510 |
| MENZEL GARRY E Director | Sale | Jul 10, 2023 | 75,056 |
| NORRY ELLIOT Officer | Sale | Jan 17, 2025 | 7,510 |
| PICCINA CINTIA Officer | Sale | Jan 15, 2025 | 18,421 |
| RAWCLIFFE ADRIAN Chief Executive Officer | Sale | Jan 17, 2025 | 44,327 |
Related Tickers
2105.HK Laekna, Inc.
13.660
-6.18%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
293.800
-4.67%
9969.HK InnoCare Pharma Limited
10.140
-3.61%
SION Sionna Therapeutics, Inc.
12.14
-3.65%
1672.HK ASCLETIS-B
6.280
-6.69%
EWTX Edgewise Therapeutics, Inc.
14.84
-3.64%
9926.HK Akeso, Inc.
98.900
-1.10%
CYTK Cytokinetics, Incorporated
40.43
+0.25%
DYN Dyne Therapeutics, Inc.
11.06
-0.45%
PCVX Vaxcyte, Inc.
32.92
-4.61%